Health Care Roundup: Market Talk

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.

0558 GMT – Given an unpromising geographic slant, EssilorLuxottica’s 1Q sales performance is impressive, analysts at Jefferies write in a note. The Franco-Italian group, maker of corrective lenses and branded sunglasses, beat analysts’ expectations for quarterly revenue, which rose 8.6% on year. “The remarkable inflection in year-on-year growth for a group overweight with U.S. consumers and with limited exposure to China does catch the eye,” Jefferies says. The investment moderately lifts its estimates for EssilorLuxottica’s full year, and raises its target price on the stock to EUR175, keeping a hold rating.(joshua.kirby@wsj.com; @joshualeokirby)